LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Erlotinib | 0.12 | uM | LJP5 | 2 | M23 | 72 | hr | 1657 | 4930 | 5505 | 0.8954 | 0.8504 |
BT-20 | Erlotinib | 0.12 | uM | LJP5 | 3 | M23 | 72 | hr | 1657 | 5002 | 5505 | 0.9085 | 0.8691 |
BT-20 | Foretinib | 0.12 | uM | LJP5 | 1 | H11 | 72 | hr | 1657 | 4716 | 5505 | 0.8566 | 0.7948 |
BT-20 | Foretinib | 0.12 | uM | LJP5 | 2 | H11 | 72 | hr | 1657 | 4595 | 5505 | 0.8346 | 0.7633 |
BT-20 | Foretinib | 0.12 | uM | LJP5 | 3 | H11 | 72 | hr | 1657 | 4846 | 5505 | 0.8802 | 0.8286 |
BT-20 | R406 | 0.12 | uM | LJP6 | 1 | C17 | 72 | hr | 1657 | 5310 | 5505 | 0.9645 | 0.9492 |
BT-20 | R406 | 0.12 | uM | LJP6 | 2 | C17 | 72 | hr | 1657 | 5649 | 5505 | 1.0260 | 1.0372 |
BT-20 | R406 | 0.12 | uM | LJP6 | 3 | C17 | 72 | hr | 1657 | 5668 | 5505 | 1.0295 | 1.0422 |
BT-20 | Pictilisib | 0.12 | uM | LJP6 | 1 | D23 | 72 | hr | 1657 | 4075 | 5505 | 0.7402 | 0.6282 |
BT-20 | Pictilisib | 0.12 | uM | LJP6 | 2 | D23 | 72 | hr | 1657 | 4518 | 5505 | 0.8206 | 0.7433 |
BT-20 | Pictilisib | 0.12 | uM | LJP6 | 3 | D23 | 72 | hr | 1657 | 4445 | 5505 | 0.8074 | 0.7244 |
BT-20 | Gefitinib | 0.12 | uM | LJP6 | 1 | N11 | 72 | hr | 1657 | 5530 | 5505 | 1.0044 | 1.0063 |
BT-20 | Gefitinib | 0.12 | uM | LJP6 | 2 | N11 | 72 | hr | 1657 | 5610 | 5505 | 1.0190 | 1.0271 |
BT-20 | Gefitinib | 0.12 | uM | LJP6 | 3 | N11 | 72 | hr | 1657 | 5026 | 5505 | 0.9129 | 0.8753 |
BT-20 | Geldanamycin | 0.12 | uM | LJP5 | 1 | O05 | 72 | hr | 1657 | 1810 | 5505 | 0.3288 | 0.0396 |
BT-20 | Geldanamycin | 0.12 | uM | LJP5 | 2 | O05 | 72 | hr | 1657 | 1993 | 5505 | 0.3620 | 0.0871 |
BT-20 | Geldanamycin | 0.12 | uM | LJP5 | 3 | O05 | 72 | hr | 1657 | 2110 | 5505 | 0.3832 | 0.1175 |
BT-20 | Geldanamycin | 0.12 | uM | LJP6 | 1 | O05 | 72 | hr | 1657 | 1954 | 5505 | 0.3549 | 0.0770 |
BT-20 | Geldanamycin | 0.12 | uM | LJP6 | 2 | O05 | 72 | hr | 1657 | 1878 | 5505 | 0.3411 | 0.0572 |
BT-20 | Geldanamycin | 0.12 | uM | LJP6 | 3 | O05 | 72 | hr | 1657 | 1833 | 5505 | 0.3329 | 0.0455 |
BT-20 | GSK1059615 | 0.12 | uM | LJP5 | 1 | E05 | 72 | hr | 1657 | 4094 | 5505 | 0.7436 | 0.6331 |
BT-20 | GSK1059615 | 0.12 | uM | LJP5 | 2 | E05 | 72 | hr | 1657 | 4425 | 5505 | 0.8037 | 0.7192 |
BT-20 | GSK1059615 | 0.12 | uM | LJP5 | 3 | E05 | 72 | hr | 1657 | 4290 | 5505 | 0.7792 | 0.6841 |
BT-20 | GSK1059615 | 0.12 | uM | LJP6 | 1 | C05 | 72 | hr | 1657 | 2760 | 5505 | 0.5013 | 0.2865 |
BT-20 | GSK1059615 | 0.12 | uM | LJP6 | 2 | C05 | 72 | hr | 1657 | 2828 | 5505 | 0.5137 | 0.3041 |